Business Standard

Tuesday, December 24, 2024 | 01:24 AM ISTEN Hindi

Notification Icon
userprofile IconSearch

Eris Lifesciences IPO subscribed 75% a day before close

Eris Life has already raised Rs 779 crore from 21 anchor investors

Eris Lifesciences subscribed 75% a day before close
Premium

.

BS Reporter Mumbai
The Rs 1,740-crore initial public offering (IPO) of Eris Lifesciences was subscribed 75 per cent on Friday. The 16-million share offering had received bids for around 12 millions shares, data provided by stock exchanges showed. 

Eris Life has already raised Rs 779 crore from 21 anchor investors, which included Goldman Sachs, Morgan Stanley and Birla Sunlife Mutual Fund. 

These investors were allotted shares at the top end of the price band of Rs 600 to Rs 603 per share. 

Eris Lifesciences is an Ahmedabad-based specialty pharma company with special focus on lifestyle-related therapeutic areas, including cardiovascular and anti-diabetics. The IPO

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in